Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Gul Cankaya

Gul Cankaya

Marmara University Pendik Training Hospital, Istanbul/ Turkey

Title: The breast-q in perioperative period for breast conserving surgery: how patient reported outcome measures contribute to health related quality of life

Biography

Biography: Gul Cankaya

Abstract

Cankaya Gul, Surgery Nurse , National Health Service Marmara University Pendik Training Hospital  Istanbul/ TURKEY

Advances in breast cancer management have reduced breast mortality rates.

The BREAST-Q is a patient reported outcome measurement (PROM) owned by

Memorial Sloan-Kettering Cancer Center and the University of British Columbia.

This questionnaire consists of six key themes  of patient satisfaction and health-related quality of life in breast surgery:

1. Satisfaction with breasts

2. Satisfaction with overall outcome

3. Psychosocial well-being

4. Sexual well-being

5. Physical well-being  and

6. Satisfaction with care

Breast augmentation is the most common cosmetic surgery procedure performed in the United States. PROMs are effective instruments guiding therapy. They allow physicians to understand the benefits that breast surgery may have to a woman’s quality of life, body image, and psychologic and sexual abilities. BREAST-Q may help  researchers  for measuring patient satisfaction with surgery-specific problems.

The BREAST-Q has been  translated into thirty languages. It quantifies the impact of cosmetic and reconstructive breast surgery (i.e., augmentation, reduction/mastopexy, mastectomy, reconstruction, and breast conserving-therapy), pre- and post-operatively. Despite widespread use of breast conservation therapy for Stage I and Stage II disease, many patients with breast cancer still receive mastectomy as a surgical treatment. Since its validation in 2009, the BREAST-Q has been used as a monitoring tool for  breast surgery providing  reliable information perioperatively.  Its multiple modules  allow researchers  to widely answer clinical questions specific to mastectomy, breast reconstruction, augmentation, and reduction/mastopexy patient populations. The standardized scoring methodology is simple to use and allows for comparisons between studies.

Our team is on way to complete BREAST-Q validation in Turkish population.